Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Dang, Shipeng ^a   Peng, Yongde ^b   Ye, Lei ^c   Wang, Yanan ^a   Qian, Zhongqing ^d   Chen, Yuqing ^d   Wang, Xiaojing ^d   Lin, Yunzhi ^d   Zhang, Xiaomei ^d   Sun, Xiyan ^e   Wu, Qiong ^a   Cheng, Yiji ^a   Nie, Hong ^a   Jin, Min ^a   Xu, Huanbai ^a,b,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d BENGBU MEDICAL COLLEGE   (China)

^e HEFEI INSTITUTES OF PHYSICAL SCIENCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR; CXCR7 PROTEIN, HUMAN; HYALURONIC ACID; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ANIMAL; ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOMA; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MOLECULAR WEIGHT; MOUSE; PATHOLOGY; THYROID TUMOR; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ADULT; AGED; ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HETEROGRAFTS; HUMANS; HYALURONIC ACID; LYMPHATIC METASTASIS; MALE; MICE; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; RECEPTORS, CXCR; THYROID NEOPLASMS; TOLL-LIKE RECEPTOR 4; TUMOR BURDEN;

EID: 84893763185     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/712561     Document Type: Article

References (41)

1. Jankovic B., Le K. T., Hershman J. M., Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? Journal of Clinical Endocrinology and Metabolism 2013 98 474 482
2. McLeod D. S., Sawka A. M., Cooper D. S., Controversies in primary treatment of low-risk papillary thyroid cancer. The Lancet 2013 381 1046 1057
3. Modi J., Patel A., Terrell R., Tuttle R. M., Francis G. L., Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes. Journal of Clinical Endocrinology and Metabolism 2003 88 9 4418 4425 2-s2.0-0141564544 10.1210/jc.2003-030342 (Pubitemid 37153752)
4. French J. D., Weber Z. J., Fretwell D. L., Said S., Klopper J. P., Haugen B. R., Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2010 95 5 2325 2333 2-s2.0-77952778924 10.1210/jc.2009-2564
5. Laurent T. C., Fraser J. R. E., Hyaluronan. FASEB Journal 1992 6 7 2397 2404 2-s2.0-0026623391
6. Underhill C. B., The interaction of hyaluronate with the cell surface: the hyaluronate receptor and the core protein. Ciba Foundation symposium 1989 143 87 100 2-s2.0-0024376938
7. Stern R., Hyaluronan catabolism: a new metabolic pathway. European Journal of Cell Biology 2004 83 7 317 325 2-s2.0-4744355223 10.1078/0171-9335- 00392 (Pubitemid 39307169)
8. Stern R., Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003 13 12 105R 115R 2-s2.0-0344668719 10.1093/glycob/cwg112 (Pubitemid 37508893)
9. Tesar B. M., Jiang D., Liang J., Palmer S. M., Noble P. W., Goldstein D. R., The role of hyaluronan degradation products as innate alloimmune agonists. The American Journal of Transplantation 2006 6 11 2622 2635 2-s2.0-33750024480 10.1111/j.1600-6143.2006.01537.x (Pubitemid 44571682)
10. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G. D., Mascarenhas M. M., Garg H. G., Quinn D. A., Homer R. J., Goldstein D. R., Bucala R., Lee P. J., Medzhitov R., Noble P. W., Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nature Medicine 2005 11 11 1173 1179 2-s2.0-30744462300 10.1038/nm1315 (Pubitemid 43093664)
11. Chambers A. F., Groom A. C., MacDonald I. C., Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer 2002 2 8 563 572 2-s2.0-0036674501 10.1038/nrc865 (Pubitemid 37328923)
12. Scheibner K. A., Lutz M. A., Boodoo S., Fenton M. J., Powell J. D., Horton M. R., Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. Journal of Immunology 2006 177 2 1272 1281 2-s2.0-33745840859 (Pubitemid 44036633)
13. Gariboldi S., Palazzo M., Zanobbio L., Selleri S., Sommariva M., Sfondrini L., Cavicchini S., Balsari A., Rumio C., Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β -defensin 2 via TLR2 and TLR4. Journal of Immunology 2008 181 3 2103 2110 2-s2.0-49649127951
14. Liu D., Pearlman E., Diaconu E., Guo K., Mori H., Haqqi T., Markowitz S., Willson J., Sy M.-S., Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7832 7837 2-s2.0-0029817452 10.1073/pnas.93.15.7832 (Pubitemid 26277124)
15. Voelcker V., Gebhardt C., Averbeck M., Saalbach A., Wolf V., Weih F., Sleeman J., Anderegg U., Simon J., Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Experimental Dermatology 2008 17 2 100 107 2-s2.0-38349056713 10.1111/j.1600-0625.2007.00638.x
16. Bourguignon L. Y. W., Wong G., Earle C. A., Xia W., Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NF B signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton 2011 68 12 671 693 2-s2.0-83555176258 10.1002/cm.20544
17. Alaniz L., Rizzo M., Malvicini M., Jaunarena J., Avella D., Atorrasagasti C., Aquino J. B., Garcia M., Matar P., Silva M., Mazzolini G., Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Letters 2009 278 1 9 16 2-s2.0-63449101042 10.1016/j.canlet.2008.12.029
18. Bohm J., Niskanen L., Tammi R., Tammi M., Eskelinen M., Pirinen R., Hollmen S., Alhava E., Kosma V.-M., Hyaluronan expression in differentiated thyroid carcinoma. Journal of Pathology 2002 196 2 180 185 2-s2.0-0036153909 10.1002/path.1032 (Pubitemid 34110899)
19. Xu H., Wu Q., Dang S., Jin M., Xu J., Cheng Y., Pan M., Wu Y., Zhang C., Zhang Y., Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS ONE 2011 6 12 2-s2.0-83355173190 10.1371/journal.pone.0027399 e27399
20. Sattar A., Rooney P., Kumar S., Pye D., West D. C., Scott I., Ledger P., Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. Journal of Investigative Dermatology 1994 103 4 576 579 2-s2.0-0028034363 (Pubitemid 24314849)
21. Black K. E., Collins S. L., Hagan R. S., Hamblin M. J., Chan-Li Y., Hallowell R. W., Hyaluronan fragments induce IFNbeta via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. Journal of Inflammation 2013 10, article 23
22. Dusio G. F., Cardani D., Zanobbio L., Mantovani M., Luchini P., Battini L., Galli V., Diana A., Balsari A., Rumio C., Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium. Immunology and Cell Biology 2011 89 5 630 639 2-s2.0-79959984703 10.1038/icb.2010.140
23. Liu-Bryan R., Terkeltaub R., Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous toll-like receptor 2/toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis and Rheumatism 2010 62 7 2004 2012 2-s2.0-77954233637 10.1002/art.27475
24. Cordo Russo R. I., Ernst G., Lompardía S., Blanco G., Álvarez É., Garcia M. G., Hajos S., Increased hyaluronan levels and decreased dendritic cell activation are associated with tumor invasion in murine lymphoma cell lines. Immunobiology 2012 217 842 850 2-s2.0-84856383816 10.1016/j.imbio.2011.12.006
25. Heldin P., Basu K., Olofsson B., Porsch H., Kozlova I., Kahata K., Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer. Journal of Biochemistry 2013 154 5 395 408 10.1093/jb/mvt085
26. Nikitovic D., Kouvidi K., Karamanos N. K., Tzanakakis G. N., The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. BioMed Research International 2013 2013 12 929531 10.1155/2013/929531
27. De Souza L. V., Matta A., Karim Z., Mukherjee J., Wang X. S., Krakovska O., Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme. Molecular Cancer 2013 12, article 74
28. Kim K. H., Jo M. S., Suh D. S., Yoon M. S., Shin D. H., Lee J. H., Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers. World Journal of Surgical Oncology 2012 10, article 193
29. Wang L., Zhao Y., Qian J., Sun L., Lu Y., Li H., Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion. Cancer 2012 119 782 791
30. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmmi H., Hoshino K., Kaisho T., Kuwata H., Takeuchi O., Takeshige K., Saitoh T., Yamaoka S., Yamamoto N., Yamamoto S., Muta T., Takeda K., Akira S., Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein I B ζ Nature 2004 430 6996 218 222 2-s2.0-3142581432 10.1038/nature02738 (Pubitemid 38902431)
31. Szajnik M., Szczepanski M., Czystowska M., Elishaev E., Mandapathil M., Nowak-Markwitz E., Expression and signaling of Toll-like receptor 4 (TLR4) and MyD88 in ovarian carcinoma cells. Journal of Clinical Oncology 2009 27 e16508
32. Zhang D., Li Y., Liu Y., Xiang X., Dong Z., Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-kappaB activation and cytokine production. Journal of Pharmacology and Experimental Therapeutics 2013 345 69 75
33. Hu H., Li Z., Zhu X., Lin R., Lin J., Peng J., Gua Lou Gui Zhi decoction suppresses LPS-induced activation of the TLR4/NF-kappaB pathway in BV-2 murine microglial cells. International Journal of Molecular Medicine 2013 31 1327 1332
34. Palová-Jelínková L., Dáňová K., Drašarová H., Dvořák M., Funda D. P., Fundová P., Pepsin digest of wheat gliadin fraction increases production of IL-1beta via TLR4/MyD88/TRIF/MAPK/NF-kappaB signaling pathway and an NLRP3 inflammasome activation. PLoS ONE 2013 8 e62426
35. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verástegui E., Zlotnik A., Involvement of chemokine receptors in breast cancer metastasis. Nature 2001 410 6824 50 56 2-s2.0-0035282432 10.1038/35065016 (Pubitemid 32225831)
36. Luker K. E., Lewin S. A., Mihalko L. A., Schmidt B. T., Winkler J. S., Coggins N. L., Thomas D. G., Luker G. D., Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene 2012 31 4750 4758 2-s2.0-84855987861 10.1038/onc.2011.633
37. Sun X., Cheng G., Hao M., Zheng J., Zhou X., Zhang J., Taichman R. S., Pienta K. J., Wang J., CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer and Metastasis Reviews 2010 29 4 709 722 2-s2.0-78449300594 10.1007/s10555-010-9256-x
38. Rajagopal S., Kim J., Ahn S., Craig S., Lam C. M., Gerard N. P., Gerard C., Lefkowitz R. J., β -Arrestin: but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proceedings of the National Academy of Sciences of the United States of America 2010 107 2 628 632 2-s2.0-76249134336 10.1073/pnas.0912852107
39. Zheng K., Li H.-Y., Su X.-L., Wang X.-Y., Tian T., Li F., Ren G.-S., Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. Journal of Experimental and Clinical Cancer Research 2010 29 1, article 31 2-s2.0-77950654038 10.1186/1756-9966-29-31
40. Hattermann K., Held-Feindt J., Lucius R., Müerköster S. S., Penfold M. E. T., Schall T. J., Mentlein R., The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Research 2010 70 8 3299 3308 2-s2.0-77951088905 10.1158/0008-5472.CAN-09- 3642
41. Maishi N., Ohga N., Hida Y., Akiyama K., Kitayama K., Osawa T., Onodera Y., Shinohara N., Nonomura K., Shindoh M., Hida K., CXCR7: a novel tumor endothelial marker in renal cell carcinoma. Pathology International 2012 62 5 309 317 2-s2.0-84860292632 10.1111/j.1440-1827.2012.02792.x